In contrast, neutralization of BMP-9 (and -10) using ALK1Fc reduced prostate cancer cell proliferation and tumor growth in vivo in an orthotopic transplantation model, as well as in the human patient-derived xenograft BM18 [67]. This evidence concerns the gene GDF2 and neoplasm.